Ferenc Szekeres

Bitr. lektor i biomedicin

Institutionen för hälsa och lärande

Kontaktuppgifter

  • Rum
  • G1407

Research areas: 
- The role of metabolism, diet and stress in cancer and obesity.
- Evaluation of new pharmaceutical compounds and their effects in the area of stroke and also in cancer. A collaboration with Glucox Biotech AB.  
______________________________________________________________________

Short CV
______________________________________________________________________
1999-2003
M.Sc - Computer Science. University of Skövde.
Thesis: “Bioinformatics applied to chlorophyll a/b binding proteins in Avena sativa (oat)” http://www.uppsatser.se/uppsats/7736e07aaf/

2003-2007
M.Sc - Computational Biology – Molecular Biology. University of Skövde.
Exam work performed at Karolinska Institutet
Thesis: “Investigation of ATP-producing pathways in skeletal muscle combined with insulin stimulation in in vitro experiments”

2007-2011
PhD - Medicine. Karolinska Institutet, Department of Molecular Medicine and Surgery (MMK), the Integrative Physiology group. 
Working with molecular biology, special focus on skeletal muscle, training and Type 2 Diabetes Mellitus, human/animal-cell culture studies.
Thesis: “Insulin Signalling and TBC1D1 in skeletal muscle metabolismhttp://publications.ki.se/jspui/handle/10616/40805

2012-2014
PostDoc - Karolinska Institutet. Department of Fysiology and Farmacology (FyFa), the Genetic Physiology group .
Working with smooth muscle physiology, metabolism and evaluation of new pharmaceutical compounds and their effects in heart and heart cells.

2014-2015
PostDoc/Senior Lab manager - Karolinska Institutet. Department of Fysiology and Farmacology (FyFa), the Genetic Physiology group / Karolinska Institutet, Wallenberg lab core facility (KIM).

2015-Present
Associate Senior Lecturer - Biomedicin, University of Skövde.

______________________________________________________________________

Supervised Final year projects:

2016
Johanna Fransson - Effects on Metabolism genes in Smooth muscles cells when inhibiting ROS production. Collaboration with HIS, Glucox Biotech AB. and Karolinska Institutet

2017
Anton Junvik - The effects of ketone bodies and Nox2 and Nox4 inhibition in metastatic prostate cancer. Collaboration with HIS and Glucox Biotech AB.

2017
Hampus Johansson - Nox2/4 inhibition in NB69 cells during ischemia/reperfusion. Collaboration with HIS and Glucox Biotech AB.

2017-2019
Freddy Moschinius - Biomarkers in cancer an meta-analysis (In progress)

2018
Charlotte Jacksson - NOX Inhibitors. A Potential Future Medicine for Ischemic Stroke. Collaboration with HIS and Glucox Biotech AB.

2018
Sadia Monzur - The Effect of nox2/4 inhibitors in t98g cells during an mimicked ischemic stroke. Collaboration with HIS and Glucox Biotech AB.

2018
David R. Alcala - The synergistic effect of ketone bodies and vitamin D on pancreas cancer cells.

2018
Nada Ali - The effects of stress on cancer (In progress)

2019 (All projects work with KEYTRUDA® (pembrolizumab) an anti-PD-1 immunotherapy that received the Nobel price in 2018).

2019
Peace Ojeka - Pancreas cancer (Panc-1) and the effect of Digitoxin and Keytruda

2019
Raquel Salus Villena - Brain Cancer glioblastom (T98G) and the effect of Digitoxin and Keytruda

2019
Miriam Ocaña Molina - Prostate cancer (LnCap) and the effect of Digitoxin and Keytruda

2019
Cristina Lozano Madueño - Hepatic cancer (HepG2) and the effect of Digitoxin and Keytruda

2019
Andreas Svensson - Pancreas cancer (BxPC-3) and the effect of Digitoxin and Keytruda

2019
Ahmed Husseini - Pancreas cancer (CFPAC-1) and the effect of Digitoxin and Keytruda

Publikationer